International Journal of Oncology

Papers
(The TQCC of International Journal of Oncology is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
[Corrigendum] Dual targeting of glioblastoma multiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol 3‑kinase inhibitor (ZSTK474)114
From mitochondrial dysregulation to ferroptosis: Exploring new strategies and challenges in radioimmunotherapy (Review)89
[Retracted] Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway88
Anti‑angiogenic effect of Bryopsis plumosa‑derived peptide via aquaporin 3 in non‑small cell lung cancer83
Nuclear miRNAs as transcriptional regulators in processes related to various cancers (Review)80
Histone lysine demethylase 3B regulates autophagy via transcriptional regulation of GABARAPL1 in acute myeloid leukemia cells71
Modulation of PD‑L1 expression by standard therapy in head and neck cancer cell lines and exosomes57
Identification and characterization of slow‑cycling cells in Ewing sarcoma53
Butyrate supplementation regulates expression of chromosome segregation 1‑like protein to reverse the genetic distortion caused by p53 mutations in colorectal cancer51
Aberrant alternative splicing in cancer: Splicing events and their regulatory mechanisms (Review)48
Tumor suppressive functions of hsa‑miR‑34a on cell cycle, migration and protective autophagy in bladder cancer48
Effect of DPP4/CD26 expression on SARS‑CoV‑2 susceptibility, immune response, adenosine (derivatives m62A and CD) regulations on patients with cancer and healthy individuals43
Role of miR‑181a‑5p in cancer (Review)40
[Retracted] Feroniellin A‑induced autophagy causes apoptosis in multidrug‑resistant human A549 lung cancer cells38
[Retracted] Interaction of S100A1 with LATS1 promotes cell growth through regulation of the Hippo pathway in hepatocellular carcinoma38
Epigenetic and epitranscriptomic role of lncRNA in carcinogenesis (Review)36
Human cytomegalovirus infection enhances 5‑lipoxygenase and cycloxygenase‑2 expression in colorectal cancer36
Targeting the cuproptosis‑associated gene COL22A1 in glioblastoma using EMD‑1204831 and kaempferol35
RAD51 and PALB2 in precision oncology: Clinical implications for HRD associated breast and ovarian cancers (Review)35
[Retracted] Interaction of YAP1 and mTOR promotes bladder cancer progression35
Endocrine nuclear receptors and long non‑coding RNAs reciprocal regulation in cancer (Review)32
Targeting PIM2 by JP11646 results in significant antitumor effects in solid tumors32
Molecular mechanisms and targeted therapy for the metastasis of prostate cancer to the bones (Review)32
Genome‑wide DNA hypomethylation drives a more invasive pancreatic cancer phenotype and has predictive occult distant metastasis and prognosis potential31
Potential role of the bitter taste receptor T2R14 in the prolonged survival and enhanced chemoresponsiveness induced by apigenin30
Transgelin promotes ferroptosis to inhibit the malignant progression of esophageal squamous cell carcinoma30
Cinobufagin inhibits M2‑like tumor‑associated macrophage polarization to attenuate the invasion and migration of lung cancer cells30
GSTO1 confers drug resistance in HCT‑116 colon cancer cells through an interaction with TNFαIP3/A2028
[Corrigendum] HIF-1α contributes to tube malformation of human lymphatic endothelial cells by upregulating VEGFR-328
[Corrigendum] Downregulation of CD147 induces malignant melanoma cell apoptosis via the regulation of IGFBP2 expression27
[Corrigendum] Receptor for activated C kinase 1 (RACK1) promotes the progression of OSCC via the AKT/mTOR pathway26
[Corrigendum] (‑)‑Epigallocatechingallate induces apoptosis in B lymphoma cells via caspase‑dependent pathway and Bcl‑2 family protein modulation26
Ageing microenvironment mediates lymphocyte carcinogenesis and lymphoma drug resistance: From mechanisms to clinical therapy (Review)24
AUP1 transcriptionally activated by KDM5B reprograms lipid metabolism to promote the malignant progression of cervical cancer24
Application of cfDNA methylation in cancer prognostic assessment: Progress and challenges (Review)24
Abnormal expression of CDC25C in NSCLC is influenced by transcriptional and RNA N6‑methyladenosine‑mediated post‑transcriptional regulation24
Current updates on the structural and functional aspects of the CRISPR/Cas13 system for RNA targeting and editing: A next‑generation tool for cancer management (Review)24
[Retracted] MicroRNA‑132 inhibits cell growth and metastasis in osteosarcoma cell lines possibly by targeting Sox423
Aberrant acetylated modification of FGF21‑KLB signaling contributes to hepatocellular carcinoma metastasis through the β‑catenin pathway23
Advancements in colorectal cancer research: Unveiling the cellular and molecular mechanisms of neddylation (Review)23
Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non‑small cell lung cancer23
Beyond the tumor microenvironment: Orchestrating systemic T‑cell response for next‑generation cancer immunotherapy (Review)23
VIM‑AS1 promotes proliferation and drives enzalutamide resistance in prostate cancer via IGF2BP2‑mediated HMGCS1 mRNA stabilization23
[Corrigendum] Long non‑coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway22
[Corrigendum] DJ‑1 promotes cell proliferation and tumor metastasis in esophageal squamous cell carcinoma via the Wnt/β‑catenin signaling pathway22
[Retracted] Effects of RUNX3 mediated Notch signaling pathway on biological characteristics of colorectal cancer cells21
Revolutionizing breast cancer treatment: Harnessing the related mechanisms and drugs for regulated cell death (Review)21
[Retracted] MicroRNA‑181a regulates epithelial‑mesenchymal transition by targeting PTEN in drug‑resistant lung adenocarcinoma cells21
Cryptotanshinone suppresses tumorigenesis by inhibiting lipogenesis and promoting reactive oxygen species production in KRAS‑activated pancreatic cancer cells20
[Expression of Concern] Establishment and evaluation of a new highly metastatic tumor cell line 5a‑D‑Luc‑ZsGreen expressing both luciferase and green fluorescent protein20
[Retracted] miR‑802 inhibits the aggressive behaviors of non‑small cell lung cancer cells by directly targeting FGFR120
Arsenic compounds induce apoptosis by activating the MAPK and caspase pathways in FaDu oral squamous carcinoma cells20
A multi‑omics study of diagnostic markers and the unique inflammatory tumor micro‑environment involved in tuberous sclerosis complex‑related renal angiomyolipoma20
Role of miRNA‑122 in cancer (Review)20
Anti‑PD‑1/PD‑L1 and anti‑CTLA‑4 associated checkpoint inhibitor pneumonitis in non‑small cell lung cancer: Occurrence, pathogenesis and risk factors (Review)20
Novel non‑metal‑based contrast agents for MR imaging: Emerging approaches and clinical perspectives (Review)19
[Retracted] NR4A1‑induced increase in the sensitivity of a human gastric cancer line to TNFα‑mediated apoptosis is associated with the inhibition of JNK/Parkin‑dependent mitophagy19
GDNF regulates lipid metabolism and glioma growth through RET/ERK/HIF‑1/SREBP‑119
LGR4 promotes proliferation and homing via activation of the NF‑κB signaling pathway in multiple myeloma19
HepaCAM‑PIK3CA axis regulates the reprogramming of glutamine metabolism to inhibit prostate cancer cell proliferation19
An overview of the regulatory role of annexin A1 in the tumor microenvironment and its prospective clinical application (Review)19
[Corrigendum] miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer19
[Retracted] MicroRNA‑873 targets HOXA9 to inhibit the aggressive phenotype of osteosarcoma by deactivating the Wnt/β‑catenin pathway19
Prolyl hydroxylase 2 inhibits glycolytic activity in colorectal cancer via the NF‑κB signaling pathway18
[Expression of Concern] MicroRNA‑195 targets VEGFR2 and has a tumor suppressive role in ACHN cells via PI3K/Akt and Raf/MEK/ERK signaling pathways18
Aurantio‑obtusin regulates lipogenesis and ferroptosis of liver cancer cells through inhibiting SCD1 and sensitizing RSL318
Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review)18
lncRNA deregulation in childhood acute lymphoblastic leukemia: A systematic review18
[Retracted] Promoter methylation of RASSF1A modulates the effect of the microtubule‑targeting agent docetaxel in breast cancer18
Emerging proteins involved in castration‑resistant prostate cancer via the AR‑dependent and AR‑independent pathways (Review)18
Ferroptosis in biliary tract cancer: Molecular mechanisms and therapeutic applications (Review)18
The regulatory effect of the YY1/miR‑HCC2/BAMBI axis on the stemness of liver cancer cells18
GBP2 enhances paclitaxel sensitivity in triple‑negative breast cancer by promoting autophagy in combination with ATG2 and inhibiting the PI3K/AKT/mTOR pathway18
Research progress on PRMTs involved in epigenetic modification and tumour signalling pathway regulation (Review)18
Role of DCLK1 in oncogenic signaling (Review)18
RPL9 acts as an oncogene by shuttling miRNAs through exosomes in human hepatocellular carcinoma cells17
[Retracted] MicroRNA‑664 targets paired box protein 6 to inhibit the oncogenicity of pancreatic ductal adenocarcinoma17
Therapeutic potentials of plant‑based antioxidants on colorectal cancer: Challenges and perspectives (Review)17
[Corrigendum] Identification of Akt1 as a potent therapeutic target for oral squamous cell carcinoma17
Significance of signal recognition particle 9 nuclear translocation: Implications for pancreatic cancer prognosis and functionality17
Mechanism of exosomes in the tumor microenvironment in the abscopal effect (Review)17
[Retracted] Tripartite motif 16 inhibits hepatocellular carcinoma cell migration and invasion17
Liproxstatin‑1 induces cell cycle arrest, apoptosis, and caspase‑3/GSDME‑dependent secondary pyroptosis in K562 cells17
Antitumor effect of memantine is related to the formation of the splicing isoform of GLG1, a decoy FGF‑binding protein16
CCDC137: A key hub for RNA and epigenetic regulation in cancer research (Review)16
Emerging role of bile acids in colorectal liver metastasis: From molecular mechanism to clinical significance (Review)16
Complement regulatory protein CD46 promotes bladder cancer metastasis through activation of MMP916
Exosome as a crucial communicator between tumor microenvironment and gastric cancer (Review)16
Ex vivo assessment of cancer drug sensitivity in epithelial ovarian cancer and its association with histopathological type, treatment history and clinical outcome15
MicroRNA in adenoid cystic carcinoma (Review)15
[Corrigendum] The role of IGFBP‑5 in mediating the anti‑proliferation effect of tetrandrine in human colon cancer cells15
[Expression of Concern] Regulation of NADPH oxidase (Nox2) by lipid rafts in breast carcinoma cells15
MELK predicts poor prognosis and promotes metastasis in esophageal squamous cell carcinoma via activating the NF‑κB pathway15
Cucurbitacin IIa promotes the immunogenic cell death‑inducing effect of doxorubicin and modulates immune microenvironment in liver cancer15
Effects of exosomes on tumor immunomodulation and their potential clinical applications (Review)15
[Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer15
miR‑382 inhibits breast cancer progression and metastasis by affecting the M2 polarization of tumor‑associated macrophages by targeting PGC‑1α15
Biological functions of circRNA in regulating the hallmarks of gastrointestinal cancer (Review)14
FGFR‑related phenotypic and functional profile of CAFs in prognostication of breast cancer (Review)14
[Corrigendum] Wnt‑signaling and apoptosis after neoadjuvant short‑term radiotherapy for rectal cancer14
Epigenetic silencing of ZCCHC10 by the lncRNA SNHG1 promotes progression and venetoclax resistance of acute myeloid leukemia14
[Retracted] Cdc42 expression in cervical cancer and its effects on cervical tumor invasion and migration14
[Corrigendum] Linc00961 inhibits the proliferation and invasion of skin melanoma by targeting the miR‑367/PTEN axis14
LncCCAT1 interaction protein PKM2 upregulates SREBP2 phosphorylation to promote osteosarcoma tumorigenesis by enhancing the Warburg effect and lipogenesis14
Correlation of SARS‑CoV‑2 to cancer: Carcinogenic or anticancer? (Review)14
Establishment of patient‑derived lung tumorspheres and their response to internal irradiation by Auger electrons14
[Corrigendum] METTL3 antagonizes 5‑FU chemotherapy and confers drug resistance in colorectal carcinoma14
Visfatin inhibits colon cancer cell apoptosis and decreases chemosensitivity to 5‑FU by promoting the SDF‑1/CXCR4/Akt axis13
Circular RNAs in osteosarcoma: An update of recent studies (Review)13
Roles of salt‑inducible kinases in cancer (Review)13
Chimeric HDAC and the cytoskeleton inhibitor broxbam as a novel therapeutic strategy for liver cancer13
[Expression of Concern] Halofuginone induces the apoptosis of breast cancer cells and inhibits migration via downregulation of matrix metalloproteinase‑913
Protein lactylation and immunotherapy in gliomas: A novel regulatory axis in tumor metabolism (Review)13
[Corrigendum] Metastasis suppressor 1 expression in human ovarian cancer: The impact on cellular migration and metastasis13
Tumour follower cells: A novel driver of leader cells in collective invasion (Review)13
RPL27 contributes to colorectal cancer proliferation and stemness via PLK1 signaling13
Targeting mitochondrial bioenergetics by combination treatment with imatinib and dichloroacetate in human erythroleukemic K‑562 and colorectal HCT‑116 cancer cells13
Receptor for activated C kinase 1 promotes cervical cancer lymph node metastasis via the glycolysis‑dependent AKT/mTOR signaling13
Use of conditional reprogramming cell, patient derived xenograft and organoid for drug screening for individualized prostate cancer therapy: Current and future perspectives (Review)13
[Retracted] Expression and function of PIM kinases in osteosarcoma13
m6A‑modified HOXC10 promotes HNSCC progression via co‑activation of ADAM17/EGFR and Wnt/β‑catenin signaling13
[Retracted] Slug contributes to cancer progression by direct regulation of ERα signaling pathway13
[Retracted] lncRNA PLAC2 activated by H3K27 acetylation promotes cell proliferation and invasion via the activation of Wnt/β‑catenin pathway in oral squamous cell carcinoma13
Targeting drug resistance in glioblastoma (Review)13
Identification of recurrent 3q13.31 chromosomal rearrangement indicates LSAMP as a tumor suppressor gene in neuroblastoma12
Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia12
Galectin‑1 binds GRP78 to promote the proliferation and metastasis of gastric cancer12
Antimicrobial agent chloroxylenol targets β‑catenin‑mediated Wnt signaling and exerts anticancer activity in colorectal cancer12
[Corrigendum] The mechanism of adenosine‑mediated activation of lncRNA MEG3 and its antitumor effects in human hepatoma cells12
USP35 promotes hepatocellular carcinoma progression by protecting PKM2 from ubiquitination‑mediated degradation12
Function of microRNA‑124 in the pathogenesis of cancer (Review)12
[Corrigendum] Curcumin reverses benzidine-induced epithelial-mesenchymal transition via suppression of ERK5/AP-1 in SV-40 immortalized human urothelial cells12
New developments in the mechanism and application of immune checkpoint inhibitors in cancer therapy (Review)12
ZBTB20 promotes ferroptosis through inhibiting TMEM109 expression in glioblastoma cells12
Impact of PD‑L1 upregulation on immune checkpoint inhibitor efficacy in triple‑negative breast cancer using a 4T1 murine model11
[Expression of Concern] MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasion11
Role of microRNAs in glycolysis in gynecological tumors (Review)11
Activation of DDX58/RIG‑I suppresses the growth of tumor cells by inhibiting STAT3/CSE signaling in colon cancer11
Tumor suppressive functions of WNT5A in rhabdomyosarcoma11
Lnc‑RGS5 sponges miR‑542‑5p to promote FoxM1/VEGFA signaling and breast cancer cell proliferation11
[Corrigendum] STAT3 activation in HER2‑overexpressing breast cancer promotes epithelial‑mesenchymal transition and cancer stem cell traits11
P2Y2R‑mediated transactivation of VEGFR2 through Src phosphorylation is associated with ESM‑1 overexpression in radiotherapy‑resistant‑triple negative breast cancer cells11
Exosomal integrins in tumor progression, treatment and clinical prediction (Review)11
[Retracted] Suppression of the death gene BIK is a critical factor for resistance to tamoxifen in MCF‑7 breast cancer cells11
mTOR in radiotherapy of lung cancer: Mechanisms of radiation resistance and therapeutic implications (Review)11
Epigallocatechin‑3‑gallate hinders metabolic coupling to suppress colorectal cancer malignancy through targeting aerobic glycolysis in cancer‑associated fibroblasts11
Role of exosomal non‑coding RNAs in cancer‑associated fibroblast‑mediated therapy resistance (Review)11
Gefitinib enhances the anti‑tumor immune response against EGFR‑mutated NSCLC by upregulating B7H5 expression and activating T cells via CD28H11
Signaling pathways and therapeutic approaches in glioblastoma multiforme (Review)11
New insights into lipid metabolism and prostate cancer (Review)11
Role and research progress of spasmolytic polypeptide‑expressing metaplasia in gastric cancer (Review)11
Death associated protein‑3 (DAP3) and DAP3 binding cell death enhancer‑1 (DELE1) in human colorectal cancer, and their impacts on clinical outcome and chemoresistance11
Chimeric antigen receptor T cells in the treatment of osteosarcoma (Review)11
0.11635589599609